{
 "id": "ep7z1py254",
 "slug": "intradermal-test",
 "title": "Intradermal test",
 "updated": "2026-10-15",
 "topic_path": [
  {
   "id": "life",
   "label": "Life and health",
   "api_url": "https://www.edgepedia.org/api/v1/topics/life"
  },
  {
   "id": "life.health",
   "label": "Human health and medicine",
   "api_url": "https://www.edgepedia.org/api/v1/topics/life.health"
  },
  {
   "id": "life.health.clinical",
   "label": "Clinical assessment and procedures",
   "api_url": "https://www.edgepedia.org/api/v1/topics/life.health.clinical"
  },
  {
   "id": "life.health.clinical.clinical-diagnostics",
   "label": "Diagnosis and clinical assessment",
   "api_url": "https://www.edgepedia.org/api/v1/topics/life.health.clinical.clinical-diagnostics"
  }
 ],
 "geo": [
  {
   "id": "geo.nongeo.t1800.life.health.clinical.clinical-diagnostics",
   "label": "Non-geographic · 1800 to 1945: Diagnosis and clinical assessment",
   "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1800.life.health.clinical.clinical-diagnostics",
   "path": [
    {
     "id": "geo.nongeo",
     "label": "Non-geographic",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo"
    },
    {
     "id": "geo.nongeo.t1800",
     "label": "Non-geographic · 1800 to 1945",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1800"
    },
    {
     "id": "geo.nongeo.t1800.life",
     "label": "Life and health",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1800.life"
    },
    {
     "id": "geo.nongeo.t1800.life.health",
     "label": "Human health and medicine",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1800.life.health"
    },
    {
     "id": "geo.nongeo.t1800.life.health.clinical",
     "label": "Clinical assessment and procedures",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1800.life.health.clinical"
    },
    {
     "id": "geo.nongeo.t1800.life.health.clinical.clinical-diagnostics",
     "label": "Diagnosis and clinical assessment",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1800.life.health.clinical.clinical-diagnostics"
    }
   ]
  },
  {
   "id": "geo.nongeo.t1946.life.health.clinical.clinical-diagnostics",
   "label": "Non-geographic · 1946 to 2000: Diagnosis and clinical assessment",
   "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.health.clinical.clinical-diagnostics",
   "path": [
    {
     "id": "geo.nongeo",
     "label": "Non-geographic",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo"
    },
    {
     "id": "geo.nongeo.t1946",
     "label": "Non-geographic · 1946 to 2000",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946"
    },
    {
     "id": "geo.nongeo.t1946.life",
     "label": "Life and health",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life"
    },
    {
     "id": "geo.nongeo.t1946.life.health",
     "label": "Human health and medicine",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.health"
    },
    {
     "id": "geo.nongeo.t1946.life.health.clinical",
     "label": "Clinical assessment and procedures",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.health.clinical"
    },
    {
     "id": "geo.nongeo.t1946.life.health.clinical.clinical-diagnostics",
     "label": "Diagnosis and clinical assessment",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.health.clinical.clinical-diagnostics"
    }
   ]
  }
 ],
 "excerpt": "An intradermal test is a diagnostic skin test that injects allergen or antigen into the dermis, detecting immediate IgE-mediated or delayed hypersensitivity, used in allergy workup and tuberculosis screening.",
 "snippet": "An intradermal test is a diagnostic skin test that injects allergen or antigen into the dermis, detecting immediate IgE-mediated or delayed hypersensitivity, used in allergy workup and tuberculosis screening.",
 "node": "life.health.clinical.clinical-diagnostics",
 "markdown": "# Intradermal test\n\nAn intradermal test is a diagnostic skin test in which a small, measured amount of allergen or antigen is injected into the dermis to detect either immediate IgE-mediated hypersensitivity or delayed type IV hypersensitivity. Immediate readings look for growth of the injection wheal within minutes; delayed readings look for induration at hours or later. The technique spans allergy workup (venom, beta-lactam and perioperative drugs, some vaccines), tuberculosis screening, and delayed-type hypersensitivity testing in infectious diseases.<sup>[1](https://repository.uantwerpen.be/docman/irua/6347fbmotoMc9)</sup><sup> • </sup><sup>[2](https://www.allergy.org.au/images/stories/pospapers/ASCIA_SPT_Manual_March_2016.pdf)</sup><sup> • </sup><sup>[3](https://www.cdc.gov/tb/hcp/testing-diagnosis/tuberculin-skin-test.html)</sup>\n\n| Key fact | Detail |\n|---|---|\n| Immediate drug IDT endpoint (EAACI/ENDA) | 0.02 mL injection; positive at 20 min only if \\( W_{20} \\ge W_{i} + 3 \\) mm with surrounding erythema<sup>[1](https://repository.uantwerpen.be/docman/irua/6347fbmotoMc9)</sup> |\n| Mantoux tuberculin test | 0.1 mL PPD, 27-gauge needle bevel-up, 6–10 mm wheal, induration read at 48–72 h<sup>[3](https://www.cdc.gov/tb/hcp/testing-diagnosis/tuberculin-skin-test.html)</sup> |\n| TST positivity thresholds | 5, 10, or 15 mm of induration depending on individual risk factors<sup>[4](https://tbksp.who.int/en/node/2029)</sup> |\n| Systemic reaction risk (inhalant/food IDT) | 0.009% overall, 0.003% major reactions; no hospitalizations or fatalities in 20,530 patients<sup>[5](https://onlinelibrary.wiley.com/doi/10.1002/alr.21091)</sup> |\n| Added yield over negative prick test | 24% additional sensitizations detected by IDT versus 9% by serum-specific IgE<sup>[6](https://pmc.ncbi.nlm.nih.gov/articles/PMC5468757/)</sup> |\n| Allergen dilution for allergy IDT | 100- to 1,000-fold dilution from skin prick test concentrations<sup>[2](https://www.allergy.org.au/images/stories/pospapers/ASCIA_SPT_Manual_March_2016.pdf)</sup> |\n| Food allergy | Contraindicated in routine practice; fatalities have been reported<sup>[7](https://www.uptodate.com/contents/diagnostic-evaluation-of-ige-mediated-food-allergy)</sup> |\n\n## How it works\n\nImmediate (type I) reactions begin when injected antigen binds IgE on the surface of mast cells and basophils, triggering biochemical events that produce histamine and other mediators; the visible result is a wheal (localized swelling) with surrounding flare of erythema.<sup>[8](https://www.hsallergy.com/wp-content/uploads/2018/07/Intradermal-Testing-362204-H05-WEB.pdf)</sup> Because the antigen is deposited directly in the dermis rather than delivered epicutaneously, the test is more sensitive than prick testing, but this sensitivity comes at the cost of specificity: clinically irrelevant sensitization produces a high rate of false positives.<sup>[9](https://www.mdpi.com/2313-5786/6/1/3)</sup>\n\nDelayed (type IV) reactions are delayed-type hypersensitivity responses rather than immediate IgE-mediated reactions. The tuberculin skin test, for example, is the intradermal injection of mycobacterial antigens that elicit a delayed-type hypersensitivity response represented by induration, measured in millimeters.<sup>[4](https://tbksp.who.int/en/node/2029)</sup> For type IV reactions, induration matters more than erythema; delayed intradermal tests are read at 48 hours, though readings from 12 hours to 4 days are used.<sup>[10](https://ijdvl.com/intradermal-tests-in-dermatology-i-tests-for-infectious-diseases/)</sup>\n\n## How it is done\n\n**Immediate allergy and drug testing.** Intradermal testing is performed only after negative prick tests, using pharmaceutical-grade injectable drugs where applicable.<sup>[2](https://www.allergy.org.au/images/stories/pospapers/ASCIA_SPT_Manual_March_2016.pdf)</sup><sup> • </sup><sup>[11](https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2020.00156/full)</sup> The standardized ENDA/EAACI method uses a tuberculin syringe (preferably 0.5 mL) with a 25, 27, or 30 G needle, bevel facing upward, piercing the skin tangentially at about a 10° angle into the upper dermis; the injection wheal serves as its own control at 4.5–5.5 mm diameter.<sup>[1](https://repository.uantwerpen.be/docman/irua/6347fbmotoMc9)</sup> Australasian perioperative guidance similarly specifies 0.02–0.05 mL raising a 3–4 mm bleb with a 26–30 gauge needle at 5–10° to the skin surface.<sup>[12](https://media.anzaag.com/2022/09/26104018/testing-guidelines.pdf)</sup> Non-round wheals are measured as \\( W_{i} = (L + w)/2 \\), taking length and perpendicular width.<sup>[1](https://repository.uantwerpen.be/docman/irua/6347fbmotoMc9)</sup> At 20 minutes the test is positive only if \\( W_{20} \\ge W_{i} + 3 \\) mm with surrounding erythema; ANZAAG accepts a wheal that doubles in size or increases by 3 mm, with a negative control under 3 mm.<sup>[1](https://repository.uantwerpen.be/docman/irua/6347fbmotoMc9)</sup><sup> • </sup><sup>[12](https://media.anzaag.com/2022/09/26104018/testing-guidelines.pdf)</sup> For non-immediate drug reactions, readings at 24, 48 hours, or later are positive when there is erythematous induration or swelling at the injection site.<sup>[1](https://repository.uantwerpen.be/docman/irua/6347fbmotoMc9)</sup> The updated EAACI statement standardizes this 0.02 mL method and the \\( W_{20} \\ge W_{i} + 3 \\) mm endpoint, and publishes first non-irritant concentrations for biologics, including rituximab 1.0 mg/mL, omalizumab 0.015 or 0.15 mg/mL, tocilizumab 1.62 mg/mL, and infliximab 1–2 mg/mL intradermally.<sup>[1](https://repository.uantwerpen.be/docman/irua/6347fbmotoMc9)</sup>\n\n**Tuberculin and delayed-type testing.** The Mantoux test injects 0.1 mL of tuberculin purified protein derivative into the inner surface of the forearm with a disposable 27-gauge tuberculin syringe, bevel upward, producing a wheal of 6 to 10 mm.<sup>[3](https://www.cdc.gov/tb/hcp/testing-diagnosis/tuberculin-skin-test.html)</sup> The reaction is read at 48 to 72 hours, measuring induration (firm swelling) in millimeters across the forearm perpendicular to its long axis; the reader should not measure erythema.<sup>[3](https://www.cdc.gov/tb/hcp/testing-diagnosis/tuberculin-skin-test.html)</sup> Interpretation is risk-stratified: induration of 5 mm or more is positive in certain high-risk groups, and thresholds of 5, 10, or 15 mm are applied according to individual clinical risk factors.<sup>[3](https://www.cdc.gov/tb/hcp/testing-diagnosis/tuberculin-skin-test.html)</sup><sup> • </sup><sup>[4](https://tbksp.who.int/en/node/2029)</sup> Across infectious-disease intradermal tests, antigen is injected into the superficial dermis through a fine-bore 26 or 27 G needle, bevel upward; the volume varies from 0.01 to 0.1 mL, but 0.1 mL is conventionally used.<sup>[10](https://ijdvl.com/intradermal-tests-in-dermatology-i-tests-for-infectious-diseases/)</sup>\n\n## Origin\n\nThe intradermal test grew out of tuberculin skin testing in the early twentieth century. Published accounts disagree on when the intradermal tuberculin technique was established: one historical account dates it to 1908, while later reviews give 1912 for the technique still in use.<sup>[13](https://doi.org/10.1136/adc.9.51.177)</sup><sup> • </sup><sup>[14](https://link.springer.com/content/pdf/10.1007/s00253-020-11062-4.pdf)</sup> Early descriptions already noted the characteristic time course of the delayed reaction, which reaches its maximum at 48 hours and then subsides.<sup>[13](https://doi.org/10.1136/adc.9.51.177)</sup>\n\n## Variants\n\n**Mantoux test.** The tuberculin variant described above, using PPD and induration thresholds of 5, 10, or 15 mm set by risk category.<sup>[3](https://www.cdc.gov/tb/hcp/testing-diagnosis/tuberculin-skin-test.html)</sup><sup> • </sup><sup>[4](https://tbksp.who.int/en/node/2029)</sup> Induration size does not correlate with the likelihood of current TB disease or future risk of developing it, so results must be read against clinical risk factors.<sup>[4](https://tbksp.who.int/en/node/2029)</sup>\n\n**Intradermal dilutional testing (serial endpoint titration).** Antigens are serially diluted 5-fold, six times, from standardized extracts usually starting at 1:20 w/v; testing begins at dilution 5 (1:62,500 w/v) or dilution 4 (1:12,500 w/v) and progresses to \\( D_{2} \\) (1:500 w/v) as the strongest. The endpoint is the weakest dilution producing a wheal 2 mm larger than the negative control, confirmed when the next stronger dilution produces a wheal at least another 2 mm larger; wheals are measured 10 to 15 minutes after injection.<sup>[15](https://www.mdpi.com/2073-4409/10/11/3224)</sup>\n\n**Leishmanin (Montenegro) test.** A delayed-type hypersensitivity test for [Leishmania](https://www.edgepedia.org/leishmania); a positive reaction is a palpable nodule more than 5 mm in diameter developing within 48 to 72 hours. It indicates delayed-type hypersensitivity, not necessarily immunity, and is not species-specific.<sup>[10](https://ijdvl.com/intradermal-tests-in-dermatology-i-tests-for-infectious-diseases/)</sup>\n\n**Histoplasmin test.** Useful in epidemiological studies such as investigating case clusters or defining endemic areas, but not predictive of histoplasmosis in an individual.<sup>[10](https://ijdvl.com/intradermal-tests-in-dermatology-i-tests-for-infectious-diseases/)</sup>\n\n**Lepromin test.** Read at four weeks and dependent on granuloma formation, a much later endpoint than other delayed-type tests.<sup>[10](https://ijdvl.com/intradermal-tests-in-dermatology-i-tests-for-infectious-diseases/)</sup>\n\n## Applications\n\nIntradermal testing is appropriate for insect venom hypersensitivity, immediate beta-lactam allergy and other drugs where validated protocols exist, and immediate hypersensitivity to some vaccines; it has an established place in [penicillin allergy testing](https://www.edgepedia.org/penicillin-allergy-testing) and may be considered for cephalosporins, insulin, opiates, anesthetic agents, and muscle relaxants.<sup>[2](https://www.allergy.org.au/images/stories/pospapers/ASCIA_SPT_Manual_March_2016.pdf)</sup> It is recommended for hospital or specialist use only, not for aeroallergens.<sup>[2](https://www.allergy.org.au/images/stories/pospapers/ASCIA_SPT_Manual_March_2016.pdf)</sup> In perioperative anaphylaxis investigation, intradermal testing has been the most common technique in Australasian centers.<sup>[12](https://media.anzaag.com/2022/09/26104018/testing-guidelines.pdf)</sup>\n\n## Limitations and alternatives\n\n**Safety.** In a 24-month prospective study across 40 practices, 80 systemic reactions (22 major) occurred among 20,530 patients receiving 878,583 intradermal wheals, an overall systemic reaction risk of 0.009% and a major-reaction risk of 0.003%, with no hospitalizations or fatalities.<sup>[5](https://onlinelibrary.wiley.com/doi/10.1002/alr.21091)</sup> The risk is nonetheless much higher than for prick testing, and deaths have been reported from intradermal testing but only one from prick testing.<sup>[2](https://www.allergy.org.au/images/stories/pospapers/ASCIA_SPT_Manual_March_2016.pdf)</sup> Because intradermal testing can precipitate anaphylaxis, in patients with high pre-test probability of IgE-mediated penicillin allergy it is recommended to commence at 1:10 or 1:100 dilution; in severe anaphylaxis, testing starts below the non-irritant concentration with stepwise titration.<sup>[16](https://www.allergy.org.au/images/stories/hp/info/ASCIA_HP_Consensus_Penicillin_Allergy_2020.pdf)</sup><sup> • </sup><sup>[1](https://repository.uantwerpen.be/docman/irua/6347fbmotoMc9)</sup> Intradermal testing is contraindicated in severe cutaneous adverse drug reactions.<sup>[11](https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2020.00156/full)</sup>\n\n**Accuracy.** Compared with prick testing, intradermal testing has higher sensitivity but markedly lower specificity, producing many false positives from clinically irrelevant sensitization, and it suffers from poor reproducibility and inter-center variability arising from differences in allergen concentration, injection depth, and timing and interpretation of skin responses.<sup>[9](https://www.mdpi.com/2313-5786/6/1/3)</sup> Skin prick testing correlates better with symptoms, and intradermal testing is considered inappropriate for the vast majority of suspected inhalant allergy because of this lack of specificity; a 2025 review frames the skin prick test as the first-line skin test for drug hypersensitivity, with the intradermal test as the second type.<sup>[2](https://www.allergy.org.au/images/stories/pospapers/ASCIA_SPT_Manual_March_2016.pdf)</sup><sup> • </sup><sup>[17](https://link.springer.com/article/10.1007/s44446-025-00031-5)</sup>\n\n**Food allergy.** Intradermal testing should not be performed in the evaluation of food allergy: it adds nothing to epicutaneous testing, significantly increases the risk of systemic reaction, and fatalities have been reported.<sup>[7](https://www.uptodate.com/contents/diagnostic-evaluation-of-ige-mediated-food-allergy)</sup> It is not recommended for routine food allergy diagnosis, and practice has shifted toward supervised oral food challenges and in vitro tests such as component-resolved diagnostics and basophil activation testing.<sup>[9](https://www.mdpi.com/2313-5786/6/1/3)</sup>\n\n## References\n\n1. [Updated EAACI Statement on Drug Hypersensitivity Skin Testing: Methodology and Non-Irritative Concentrations](https://repository.uantwerpen.be/docman/irua/6347fbmotoMc9)\n2. [ASCIA Skin Prick Testing Manual (2016), intradermal testing section](https://www.allergy.org.au/images/stories/pospapers/ASCIA_SPT_Manual_March_2016.pdf)\n3. [Clinical Testing Guidance for Tuberculosis: Tuberculin Skin Test | CDC](https://www.cdc.gov/tb/hcp/testing-diagnosis/tuberculin-skin-test.html)\n4. [Annex 2. Tuberculin skin testing: administration, reading and interpretation | WHO TB Knowledge Sharing](https://tbksp.who.int/en/node/2029)\n5. [Safety of intradermal skin tests for inhalants and foods: a prospective study](https://onlinelibrary.wiley.com/doi/10.1002/alr.21091)\n6. [Diagnosing environmental allergies: Comparison of skin-prick, intradermal, and serum specific immunoglobulin E testing](https://pmc.ncbi.nlm.nih.gov/articles/PMC5468757/)\n7. [Diagnostic evaluation of IgE-mediated food allergy - UpToDate](https://www.uptodate.com/contents/diagnostic-evaluation-of-ige-mediated-food-allergy)\n8. [Allergenic Extracts Intradermal Testing (manufacturer prescribing/technical document)](https://www.hsallergy.com/wp-content/uploads/2018/07/Intradermal-Testing-362204-H05-WEB.pdf)\n9. [Diagnosis of Food Allergy: Which Tests Truly Have Clinical Value?](https://www.mdpi.com/2313-5786/6/1/3)\n10. [Intradermal tests in dermatology-I: Tests for infectious diseases](https://ijdvl.com/intradermal-tests-in-dermatology-i-tests-for-infectious-diseases/)\n11. [Intradermal Tests With Drugs: An Approach to Standardization](https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2020.00156/full)\n12. [ANZAAG Perioperative Anaphylaxis Investigation Guidelines (September 2017, updated 2022)](https://media.anzaag.com/2022/09/26104018/testing-guidelines.pdf)\n13. [The Intradermal Tuberculin Reaction: With special reference to so-called surgical tuberculosis](https://doi.org/10.1136/adc.9.51.177)\n14. [Skin tests for the detection of Mycobacterial infections: achievements, current perspectives, and implications for other diseases](https://link.springer.com/content/pdf/10.1007/s00253-020-11062-4.pdf)\n15. [Clinical Relevance and Advantages of Intradermal Test Results in 371 Patients with Allergic Rhinitis, Asthma and/or Otitis Media with Effusion](https://www.mdpi.com/2073-4409/10/11/3224)\n16. [ASCIA Consensus Penicillin Allergy (2020)](https://www.allergy.org.au/images/stories/hp/info/ASCIA_HP_Consensus_Penicillin_Allergy_2020.pdf)\n17. [Towards standardized skin testing for drug-induced allergic reactions | Saudi Pharmaceutical Journal](https://link.springer.com/article/10.1007/s44446-025-00031-5)\n\n---\n*Topic: Encyclopedia › Life and health › Human health and medicine › Clinical assessment and procedures › Diagnosis and clinical assessment*\n\n*Initially written Sep 29, 2026 · Edited: Oct 15, 2026*\n\n*Copyright 2026 EdgeChat AI, a subsidiary of Biostate AI.*\n\nLicense: Edgepedia Community License 1.0, https://www.edgepedia.org/edgepedia/license\n",
 "same_as": [],
 "url": "https://www.edgepedia.org/intradermal-test",
 "markdown_url": "https://www.edgepedia.org/intradermal-test.md",
 "license": {
  "name": "Edgepedia Community License 1.0",
  "url": "https://www.edgepedia.org/edgepedia/license",
  "summary": "Free with credit, commercial use included. AI training is open to everyone. For other uses, organizations over USD 100M in revenue or 100M monthly users license separately.",
  "spdx": "LicenseRef-Edgepedia-Community-1.0"
 },
 "credit": "\"Intradermal test\", Edgepedia (EdgeChat), https://www.edgepedia.org/intradermal-test. Edgepedia Community License 1.0.",
 "credit_md": "\"[Intradermal test](https://www.edgepedia.org/intradermal-test)\", Edgepedia (EdgeChat), [https://www.edgepedia.org/intradermal-test](https://www.edgepedia.org/intradermal-test). [Edgepedia Community License 1.0](https://www.edgepedia.org/edgepedia/license).",
 "credit_html": "\"<a href=\"https://www.edgepedia.org/intradermal-test\">Intradermal test</a>\", Edgepedia (EdgeChat), <a href=\"https://www.edgepedia.org/intradermal-test\">https://www.edgepedia.org/intradermal-test</a>. <a href=\"https://www.edgepedia.org/edgepedia/license\">Edgepedia Community License 1.0</a>.",
 "speakable": "An intradermal test is a diagnostic skin test that injects allergen or antigen into the dermis, detecting immediate IgE-mediated or delayed hypersensitivity, used in allergy workup and tuberculosis screening."
}
